Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Galapagos ( (GLPG) ) has issued an announcement.
On March 4, 2026, Galapagos reported that it had received transparency notifications from Bank of America Corporation, revealing changes in the bank’s position in Galapagos’ voting rights and equivalent financial instruments during late February. Under Belgian transparency law, Bank of America and its affiliates first crossed above the 5% threshold of Galapagos’ voting rights and equivalent financial instruments on February 26, 2026, then adjusted their holdings so that by February 27, BofA Securities, Inc. fell back below 5% in voting rights while the group as a whole still held a notable exposure.
As of March 2, 2026, Bank of America and its affiliates held 292,642 voting rights and 3,491,679 equivalent financial instruments in Galapagos, together representing 5.74% of the company’s 65,897,071 outstanding shares. The disclosures, largely driven by transactions in rights of use, rights to recall, options and swaps, underscore continuing institutional interest in Galapagos stock and provide investors with greater visibility on the ownership dynamics surrounding the biotech group.
The most recent analyst rating on (GLPG) stock is a Buy with a $37.00 price target. To see the full list of analyst forecasts on Galapagos stock, see the GLPG Stock Forecast page.
Spark’s Take on GLPG Stock
According to Spark, TipRanks’ AI Analyst, GLPG is a Neutral.
GLPG scores strongest on financial positioning (very low leverage and large cash resources) and supported valuation (low P/E). The main offset is persistent negative operating/free cash flow and earnings quality concerns highlighted by non-recurring profit drivers and ongoing restructuring/wind-down cash needs; technical signals are broadly neutral.
To see Spark’s full report on GLPG stock, click here.
More about Galapagos
Galapagos NV is a Belgium-based biotechnology company listed on Euronext and Nasdaq under the ticker GLPG. It focuses on the research and development of innovative medicines, with its shares subject to EU and Belgian regulatory regimes, including transparency rules on significant shareholdings that are closely watched by international institutional investors.
Average Trading Volume: 104,405
Technical Sentiment Signal: Buy
Current Market Cap: $2.18B
See more data about GLPG stock on TipRanks’ Stock Analysis page.